Supramedullary influences on cough

Respiratory Physiology & Neurobiology
John WiddicombeGiovanni A Fontana

Abstract

The evidence for supramedullary influences on cough is largely indirect. Cough can be voluntarily induced or inhibited, functions usually thought to reside in the cerebral cortex. A sensation of 'urge-to-cough' usually precedes cough due to an airway irritant stimulus, and this may well involve the cerebral cortex. In conditions with interruption of the pathways between the cortex and the brainstem, such as strokes and Parkinson's disease, voluntary cough may be inhibited without disruption of reflex cough from the larynx or lower airways. 'Habit cough', like Tourette's syndrome, is assumed to be cortically mediated. Placebos and many treatments based on complementary medicine are effective in inhibiting clinical cough, and the site of action is likely to be the cerebral cortex. In sleep and in anaesthesia cough is depressed and, again, this seems likely to be at a cortical level. However there are few or no experimental or clinical observation as to the localization and functions of supramedullary areas responsible for cough. It is a field of research wide open for exploration.

References

Sep 1, 1992·Respiration Physiology·F B Sant'AmbrogioG Sant'Ambrogio
Sep 1, 1988·Journal of Communication Disorders·F B BlagerR P Wood
Aug 1, 1994·The Journal of Pharmacy and Pharmacology·R Eccles
Jun 4, 1999·Stroke; a Journal of Cerebral Circulation·W R AddingtonK A Gilliland
Jun 29, 2001·Acta Physiologica Hungarica·J Korpas, J Jakus
Jul 9, 2002·Pulmonary Pharmacology & Therapeutics·Donald C Bolser, Paul W Davenport
Jul 9, 2002·Pulmonary Pharmacology & Therapeutics·R Eccles
Jul 9, 2002·Pulmonary Pharmacology & Therapeutics·P C L LeeR Eccles
Apr 22, 2003·American Journal of Physical Medicine & Rehabilitation·Robert E StephensJohn G Widdicombe
Sep 13, 2003·Chest·Satoru EbiharaHidetada Sasaki
Feb 5, 2004·The Journal of Pediatrics·Ran D Anbar, Howard R Hall
Mar 9, 2004·Yonsei Medical Journal·Hüseyin TanAdem Arik
Nov 27, 2004·Pulmonary Pharmacology & Therapeutics·R ShannonB G Lindsey
Nov 27, 2004·Pulmonary Pharmacology & Therapeutics·J FongA Guz
Jan 18, 2005·Respiratory Physiology & Neurobiology·Hans RajA S Paintal
Apr 6, 2006·Respiratory Physiology & Neurobiology·Jan HanacekJohn Widdicombe
Jul 4, 2006·The European Respiratory Journal·J Widdicombe, G Fontana
Jan 1, 1949·Archives of Neurology and Psychiatry·W PENFIELD, T RASMUSSEN

❮ Previous
Next ❯

Citations

Nov 21, 2008·Cough·Shinsuke YamandaHiroyuki Arai
Oct 12, 2010·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Brendan J Canning, Nanako Mori
Oct 14, 2009·Lung·Kai K Lee, Surinder S Birring
Feb 27, 2013·Respiratory Physiology & Neurobiology·S GavliakovaJ Plevkova
Apr 3, 2012·Pulmonary Pharmacology & Therapeutics·Paul M WisePamela Dalton
Jan 11, 2011·Pulmonary Pharmacology & Therapeutics·J WiddicombeUNKNOWN Other participants
Oct 13, 2010·Pulmonary Pharmacology & Therapeutics·Satoru Ebihara, Takae Ebihara
Feb 23, 2010·Otolaryngologic Clinics of North America·Anne B Chang, Robert G Berkowitz
Nov 8, 2015·Pulmonary Pharmacology & Therapeutics·Justin GarnerElisabetta Renzoni
Sep 23, 2008·Pulmonary Pharmacology & Therapeutics·Stuart B MazzoneMichael J Farrell
Dec 27, 2011·Experimental Physiology·Teresa PittsDonald Bolser
Apr 22, 2008·Lancet·Kian Fan Chung, Ian D Pavord
Jun 19, 2007·NeuroImage·Kristina SimonyanChristy L Ludlow
Feb 13, 2007·Pulmonary Pharmacology & Therapeutics·Giovanni A Fontana, John Widdicombe
Sep 26, 2006·Respiratory Physiology & Neurobiology·Thomas HummelDavid Hull
Nov 9, 2014·Expert Opinion on Pharmacotherapy·Nicole M Ryan
Nov 15, 2011·Cough·Stuart M Brooks
Jul 19, 2016·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·N VilardellP Clavé
Feb 10, 2017·The European Respiratory Journal·Surinder S Birring
Jan 16, 2007·Current Opinion in Allergy and Clinical Immunology·Anne E VertiganAlison L Winkworth
Jun 19, 2007·American Journal of Respiratory and Critical Care Medicine·Stuart B MazzoneMichael J Farrell
Oct 26, 2013·Current Opinion in Otolaryngology & Head and Neck Surgery·Megan M Cornere
Aug 17, 2010·Southern Medical Journal·Selmin Karatayli-OzgursoyJuan C Guarderas
Feb 27, 2010·Journal of Applied Physiology·Donald C Bolser
May 23, 2017·Current Physical Medicine and Rehabilitation Reports·Stephanie A WattsEmily K Plowman
Apr 1, 2017·Journal of Applied Physiology·Alexandra E BrandimoreMichelle S Troche
Mar 6, 2010·The Medical Journal of Australia·Peter G GibsonUNKNOWN CICADA
Feb 22, 2021·Asian Journal of Surgery·Xin LiChunfang Zhang
Jun 22, 2021·PloS One·M Nicholas MusselwhiteDonald C Bolser

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.